Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Heart Fail Rev ; 28(6): 1297-1306, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37644366

ABSTRACT

Many cardiology associations endorse the role of the cardiopulmonary exercise test (CPET) to define the severity of impairment of functional capacity in individuals with heart failure with reduced ejection fraction (HFrEF) and when evaluating the need for advanced therapies for these patients. The focus of the CPET within the cardiology community has been on peak volume of oxygen uptake (VO2). However, several CPET variables are associated with outcomes in individuals with and without chronic disease and can inform clinical decisions in individuals with HFrEF. In this manuscript, we will review the normal cardiopulmonary response to a graded exercise test and review current guideline recommendations relative to CPET in patients with HFrEF.

2.
J Intensive Care Med ; 38(1): 21-26, 2023 Jan.
Article in English | MEDLINE | ID: mdl-35815883

ABSTRACT

Purpose: Elevated ferritin levels are associated with poor outcomes in Covid-19 patients. Optimal timing of ferritin assessment and the merit of longitudinal values remains unclear. Methods: Patients admitted to Henry Ford Hospital with confirmed SARS-CoV-2 were studied. Regression models were used to determine the relation between ferritin and mortality, need for mechanical ventilation, ICU admission, and days on the ventilator. Results: 2265 patients were evaluated. Patients with an initial ferritin of > 490 ng/mL had an increased risk of death (OR 3.4, P < .001), admission to the ICU (OR 2.78, P < .001) and need for mechanical ventilation (OR 3.9, P < .001). There was no difference between admission and Day 1 ICU ferritin levels (611.5 ng/mL vs. 649 ng/mL respectively; P = .07). The decline in ferritin over ICU days 1-4 was similar between survivors and non-survivors. A change in ferritin levels from admission to ICU Day 1 (P = .330), or from ICU Day 1 to 2 (P = .788), did not predict days on the ventilator. Conclusions: Initial Ferritin levels were highly predictive of ICU admission, the need for mechanical ventilation and in-hospital mortality. However, longitudinal measures of ferritin throughout the hospital stay did not provide additional predictive value.


Subject(s)
COVID-19 , Humans , COVID-19/therapy , SARS-CoV-2 , Respiration, Artificial , Ventilators, Mechanical , Ferritins , Intensive Care Units , Retrospective Studies
3.
Crit Care Med ; 49(3): 482-489, 2021 03 01.
Article in English | MEDLINE | ID: mdl-33372746

ABSTRACT

OBJECTIVES: To investigate the potential influence of racial differences in outcomes of patients infected by coronavirus disease 2019-positive patients who require intensive care in an urban hospital. DESIGN: Retrospective cohort study. SETTING: Henry Ford Health System Multidisciplinary ICU, a total of 156 beds spread throughout the hospital in Detroit, MI. PATIENTS: We obtained data from the electronic medical record of all adult severe acute respiratory syndrome coronavirus-2-positive patients managed in the ICU of Henry Ford Hospital in Detroit, MI, between March 13, 2020, and July 31, 2020. Included patients were divided into two groups: people of color (including Black, Asian, Hispanic/Latino, and Arab) and White. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A total of 365 patients were evaluated: 219 were Black (60.0%), 129 were White (35.3%), two were Asian (0.6%), eight were Hispanic/Latino (2.2%), and seven were Arab (1.9%). People of color were younger (62.8 vs 67.1; p = 0.007), with equal distribution of sex. People of color had less coronary artery disease (34 [14.4%] vs 35 [27.1%]; p =0.003) and less self-reported use of regular alcohol consumption (50 [21.2%] vs 12 [9.3%]; p = 0.004) than Whites, with no differences in diabetes (125 [53.0%] vs 66 [51.2%]; p = 0.742), hypertension (188 [79.7%] vs 99 [76.8%]; p = 0.516), congestive heart failure (41 [17.4%] vs 32 [24.8%]; p = 0.090), or chronic kidney disease (123 [54.1%] vs 55 [42.6%]; p = 0.083).There was no difference in ICU length of stay between people of color (18 d [CI, 7-47 d]) and Whites (18 d [CI, 6-48 d]; p = 0. 0.979). Neither frequency (72.5% vs 71.3%; p = ns) nor median time to mechanical ventilation between people of color (9 d [CI, 6-15 d]) and Whites (10 d [CI, 5-16 d]; p = 0.733) was different. Overall, 188 patients (51.5 %) died in the hospital. The 28-day mortality was lower in people of color (107/236; 45.3%) versus Whites (73/129; 56.6%) (adjusted odds ratio 0.60; p = 0.034), and there was an increased median survival time in people of color (20 d) versus Whites (13.5 d; hazard ratio 0.62; p = 0.002). The inhospital mortality was lower in people of color versus White, but the difference was not statistically significant (113 [47.9%] vs 75 [58.1%], respectively; p = 0.061). Finally, there was no significant difference in days of symptoms prior to admission, frequency of presenting symptoms, or frequency or severity of acute respiratory distress syndrome between the two groups. CONCLUSIONS: In critically ill patients infected with coronavirus disease 2019, people of color had a lower 28-day mortality than Whites with no difference in hospital mortality, ICU length of stay, or rates of intubation. These findings are contrary to previously held beliefs surrounding the pandemic.


Subject(s)
COVID-19/ethnology , Critical Care Outcomes , Critical Care , Ethnicity , Hospitalization , Race Factors , Aged , Female , Hospital Mortality , Humans , Length of Stay , Male , Michigan/epidemiology , Middle Aged , Retrospective Studies , Tertiary Care Centers , Time-to-Treatment
4.
J Intensive Care Med ; 35(12): 1471-1475, 2020 Dec.
Article in English | MEDLINE | ID: mdl-30836814

ABSTRACT

OBJECTIVE: The purpose of this study is to determine whether in patients admitted to a medical intensive care unit (ICU) service there are outcome differences between those in a medical ICU bed ("home") and a geographically distant subspecialty ICU bed ("overflow"). METHODS: We performed a retrospective cohort study of 4091 patients admitted to a medical ICU of a large tertiary-care urban teaching hospital. Depending on bed availability, some patients were housed in surgical or cardiac subspecialty ICUs while still being cared for by the primary medical ICU service. We assessed the association of these overflow patients with readmission rates and ICU and hospital length of stay (LOS). Potential differences in care was assessed by measuring the number of central line days, urinary catheter days, and ventilator days. RESULTS: Of the 4091 consecutive patients admitted to the medical ICU, 362 (9%) were housed in an overflow ICU and 3729 (91%) were home patients. There was no difference in demographics, patient characteristics, ICU admission diagnosis, or risk of mortality between the 2 groups. Compared to home patients, overflow patients had a higher rate of readmission to the ICU (10.5% vs 6.63% respectively P = .006), a slightly shorter ICU LOS (median 2 [interquartile range, IQR: 1-4] days versus home group of 2 [IQR: 1-5] days; P = .001), and a slightly longer hospital LOS (overflow 7 [IQR: 4-17] days vs home 7 [IQR: 4-13] days, P = .001). There was no differences in number of central venous catheter days, urinary catheter days, ventilator days, or mortality. CONCLUSIONS: Medical ICU patients who are housed in ICUs geographically distant from the primary team's location have increased morbidity when compared to patients admitted to the home ICU. However, there are no differences in number of central venous catheter days, urinary catheter days, ventilator days, or mortality.


Subject(s)
Critical Care , Intensive Care Units , Health Services Accessibility , Hospital Mortality , Hospitalization , Humans , Length of Stay , Retrospective Studies , Social Determinants of Health , Travel , Treatment Outcome
5.
Crit Care Med ; 36(3): 812-7, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18431268

ABSTRACT

OBJECTIVE: The purpose of this study is to evaluate factors associated with decisions to reject patients from medical intensive care unit (MICU) admission and assess the outcome of these patients. DESIGN: Prospective, observational cohort study. SETTING: Large tertiary referral, teaching hospital. PATIENTS: Consecutive patients evaluated for MICU admission but not admitted. MEASUREMENTS: Patient characteristics and demographics, location of evaluation, clinical and laboratory data, major organ system dysfunction, 48-hr patient status, and 6-month mortality. MAIN RESULTS: A total of 1,302 patients were admitted to the MICU, 353 patients were evaluated for the MICU but were not admitted, and 324 patients were used in analysis. Mean age was 68.6 +/- 17.1 yrs, and 57.7% were women. Hospice care was instituted during or immediately after evaluation in 8.3% (n = 27) of cases. MICU care was declined by the patient in 5.2% (n = 17) of evaluations. The mean Acute Physiology and Chronic Health Evaluation (APACHE) II score was 17.4 +/- 6.0. Factors associated with death at 6 months included age, APACHE II score, entering hospice, and patient choice to decline care. Of the patients considered too well to benefit, 9% were admitted to the MICU within 48 hrs and 35.5% died within 6 months; however, no deaths occurred within 48 hrs. CONCLUSIONS: Patients who are considered for critical care are at very high risk of mortality within 6 months. Given that no deaths occurred within 48 hrs and that only 9% needed intensive care unit admission within 48 hrs, the house staff's decision process is safe at this one institution.


Subject(s)
Critical Illness , Intensive Care Units , Triage , Adult , Aged , Aged, 80 and over , Critical Illness/mortality , Critical Illness/therapy , Female , Humans , Male , Middle Aged , Patient Admission/standards , Prognosis , Prospective Studies
6.
Am J Crit Care ; 22(1): 54-60, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23283089

ABSTRACT

BACKGROUND: How compliance with a ventilator bundle is monitored varies from institution to institution. Some institutions rely on the primary intensive care unit team to review the bundle during their rounds; others rely on a separate team of health care personnel that may include representatives from disciplines such as nursing, respiratory therapy, and pharmacy. OBJECTIVES: To compare rates of compliance with ventilator bundle components between a dedicated ventilator bundle rounding team and the primary intensive care unit rounding team in a 68-bed medical intensive care unit. METHODS: A query of the medical intensive care unit's database was used to retrospectively determine rates of compliance with specific ventilator bundle components at a tertiary care hospital in an urban community for 1 year. RESULTS: Compared with the intensive care unit rounding team, the ventilator bundle rounding team had better compliance with sedation vacation (61.7% vs 54.0%, P < .001). Rates of compliance with spontaneous breathing trials and prophylaxis of peptic ulcer disease were similar in both study groups. CONCLUSIONS: A dedicated ventilator bundle rounding team improves compliance with sedation vacation, but not with spontaneous breathing trials and prophylaxis of peptic ulcer disease. In a large-volume tertiary center, a dedicated ventilator bundle rounding team may be more effective than the primary rounding team in achieving compliance with some bundle components.


Subject(s)
Guideline Adherence , Intensive Care Units , Nursing, Team/methods , Respiration, Artificial/nursing , Respiration, Artificial/standards , Ventilator Weaning/nursing , Ventilator Weaning/standards , Aged , Female , Humans , Male , Middle Aged , Retrospective Studies , Tertiary Care Centers
7.
J Pathol ; 201(3): 343-54, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14595745

ABSTRACT

Idiopathic pulmonary fibrosis (IPF) is a progressive, usually fatal, form of interstitial lung disease characterized by failure of alveolar re-epithelialization, persistence of fibroblasts/myofibroblasts, deposition of extracellular matrix, and distortion of lung architecture which ultimately results in respiratory failure. Clinical IPF is associated with a histopathological pattern of usual interstitial pneumonia (UIP) on surgical lung biopsy. Therapy for this disease with glucocorticoids and other immunomodulatory agents is largely ineffective and recent trials of newer anti-fibrotic agents have been disappointing. While the inciting event(s) leading to the initiation of scar formation in UIP remain unknown, recent advances in our understanding of the mechanisms underlying both normal and aberrant wound healing have shed some light on pathogenetic mechanisms that may play significant roles in this disease. Unlike other fibrotic diseases of the lung, such as those associated with collagen vascular disease, occupational exposure, or chemotherapeutic agents, UIP is not associated with a significant inflammatory response; rather, dysregulated epithelial-mesenchymal interactions predominate. Identification of pathways crucial to fibrogenesis might offer potentially novel therapeutic targets to slow or halt the progression of IPF. This review focuses on evolving concepts of cellular and molecular mechanisms in the pathogenesis of UIP/IPF.


Subject(s)
Pulmonary Fibrosis/pathology , Epithelium/pathology , Extracellular Matrix/pathology , Fibroblasts/pathology , Humans , Lung/pathology , Pulmonary Alveoli/pathology , Pulmonary Fibrosis/drug therapy , Pulmonary Fibrosis/epidemiology
8.
Am J Respir Cell Mol Biol ; 31(6): 672-8, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15308506

ABSTRACT

The pathogenesis of pulmonary fibrosis is thought to involve alveolar epithelial injury that, when successfully repaired, can limit subsequent scarring. The plasminogen system participates in this process with the balance between urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor-1 (PAI-1) being a critical determinant of the extent of collagen accumulation that follows lung injury. Because the plasminogen system is known to influence the rate of migration of epithelial cells, including keratinocytes and bronchial epithelial cells, we hypothesized that the balance of uPA and PAI-1 would affect the efficiency of alveolar epithelial cell (AEC) wound repair. Using an in vitro model of AEC wounding, we show that the efficiency of repair is adversely affected by a deficiency in uPA or by the exogenous administration of PAI-1. By using PAI-1 variants and AEC from mice transgenically deficient in vitronectin (Vn), we demonstrate that the PAI-1 effect requires its Vn-binding activity. Furthermore, we have found that cell motility is enhanced by the availability of Vn in the matrix and that the AEC-Vn interaction is mediated, in part, by the alpha(v)beta(1) integrin. The significant effect of uPA and PAI-1 on epithelial repair suggests a mechanism by which the plasminogen system may modulate pulmonary fibrosis.


Subject(s)
Bleomycin/analogs & derivatives , Plasminogen Activator Inhibitor 1/pharmacology , Pulmonary Alveoli/drug effects , Pulmonary Alveoli/pathology , Vitronectin/metabolism , Wound Healing/drug effects , Animals , Bleomycin/pharmacology , Cell Line, Tumor , Cell Movement , Collagen/metabolism , Humans , Mice , Mice, Knockout , Protein Binding , Pulmonary Alveoli/metabolism , Pulmonary Fibrosis/chemically induced , Pulmonary Fibrosis/metabolism , Urokinase-Type Plasminogen Activator/pharmacology , Vitronectin/deficiency , Vitronectin/genetics
SELECTION OF CITATIONS
SEARCH DETAIL